Alloreactivity of natural killer cells in allogeneic liver transplantation

Transplantation

Volumn 72, Issue 1, 2001, Pages 116-122

  Oertel, Michael ^a,b   Kohlhaw, Kay ^b   Diepolder, Helmut M ^c   Schröder, Sabine ^b   Schwarz, Rene ^b   Tannapfel, Andrea ^b   Mössner, Joachim ^b   Hauss, Johann ^b   Berr, Frieder ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA C ANTIGEN;

ADOLESCENT; ADULT; ALLOGRAFT; ALLOIMMUNITY; ANTIGEN RECOGNITION; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CYTOLYSIS; CYTOTOXICITY; EFFECTOR CELL; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MALE; MIXED LYMPHOCYTE CULTURE; NATURAL KILLER CELL; PRIORITY JOURNAL;

ACUTE DISEASE; ADOLESCENT; ADULT; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GRAFT REJECTION; HUMANS; ISOANTIBODIES; KILLER CELLS, NATURAL; LEUKOCYTE COUNT; LIVER TRANSPLANTATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MIDDLE AGED; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035879344     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200107150-00023     Document Type: Article

References (35)

1. T-lymphocyte-antigen interactions in transplant rejection
2. The role of T-cell costimulatory activation pathways in transplant rejection
3. Are dendritic cells the key to liver transplant tolerance?
4. Cyclosporin A initially as the only immunosuppressant in 34 patients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers
5. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes
6. Acute hepatic allograft rejection: Incidence, risk factors and impact on outcome
7. Rejection in liver transplantation
8. HLA compatibility and liver transplant outcome: Improved patient survival by HLA and cross-matching
9. Influence of human leucocyte antigen matching on liver allograft survival and rejection: "The dualistic effect"
10. In search of the "missing self": MHC molecules and NK recognition
11. Receptors for HLA class-I molecules in human natural killer cells
12. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors
13. Natural killer cells: From no receptors to many
14. Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C
15. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80
16. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection
17. Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor
18. Banff schema for grading liver allograft rejection: An international consensus document
19. Apoptosis and the expression of Fas and Fas ligand (FasL) antigen in rejection and reinfection in liver allograft specimens
20. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation
21. - lymphocytes in mixed lymphocyte culture
22. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome
23. Influence of HLA matching and DNA typing on kidney and heart transplant survival in black recipients
24. Human leukocyte antigen compatibility in heart transplantation: Evidence for a differential role of HLA matching on short- and medium-term patient survival
25. HLA matching in liver transplantation: A retrospective analysis
26. Distribution of lymphocyte subtypes in liver transplant recipients
27. Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to cyclosporine or FK506
28. Effect of FK-506 and cyclosporine on human lymphocyte responses in vitro
29. Effect of FK506 versus cyclosporine on human natural and antibody-dependent cytotoxicity reactions in vitro
30. Threonine 80 on HLA-B27 confers protection against lysis by a group of natural killer clones
31. Lymphokine-activated killer cell phenomenon: Lysis of natural killer-resistant flesh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes
32. The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells
33. The IL-2 receptor β chain (p70): Role in mediating signals for LAK, NK, and proliferative activities
34. Novel interleukin 2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells
35. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibility complex haplotype